Clinical and laboratory parameters that had a significant change in patients with rejection were used: HCC diagnosis before LT, AST, ALT, gamma-glutamyl transpeptidase (GGT) and bilirubin. Here, GGTLC1 is linked to hepatocellular carcinoma.